New York, NY, United States of America

Doris Bucher


 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Doris Bucher: Innovator in Influenza Vaccine Development

Introduction

Doris Bucher is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of medical science, particularly in the development of vaccines. With a total of 2 patents, her work focuses on innovative solutions to combat influenza virus infections.

Latest Patents

Doris Bucher's latest patents revolve around the development of M1 polypeptides that serve as vaccines and antigens. These inventions aim to generate anti-M1 polypeptide antibodies for the prophylactic treatment of individuals susceptible to influenza virus infections. The anti-M1 polypeptide antibodies are designed to be effective for treating individuals already infected with the virus, as well as for immune-suppressed individuals who cannot generate an effective antibody response.

Career Highlights

Doris Bucher is currently associated with Engen Bio, Inc., where she continues to advance her research and innovations in the field of vaccines. Her dedication to improving public health through scientific research is evident in her work.

Collaborations

Doris collaborates with notable colleagues, including Mark Alfenito and Mark Baer, who contribute to her research efforts and innovations.

Conclusion

Doris Bucher is a trailblazer in the field of vaccine development, particularly for influenza. Her innovative work and collaborations are paving the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…